.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Merck
Teva
Fish and Richardson
Medtronic
Accenture
Federal Trade Commission
Farmers Insurance
Moodys
Boehringer Ingelheim

Generated: December 16, 2017

DrugPatentWatch Database Preview

Patents Expiring in August 2023

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use
AllerganLATISSEbimatoprostSOLUTION/DROPS;TOPICAL022369-001Dec 24, 2008ATRXYesYes► Subscribe► SubscribeYYTREATMENT OF HYPOTRICHOSIS OF THE EYELASHES BY INCREASING THEIR GROWTH INCLUDING LENGTH, THICKNESS AND DARKNESS
Merz PharmsCUVPOSAglycopyrrolateSOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► SubscribeREDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA)IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
Merz PharmsCUVPOSAglycopyrrolateSOLUTION;ORAL022571-001Jul 28, 2010RXYesYes► Subscribe► SubscribeREDUCE CHRONIC SEVERE DROOLING (I.E., SIALORRHEA)IN PATIENTS WITH NEUROLOGIC CONDITIONS ASSOCIATED WITH PROBLEM DROOLING
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-001Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-004Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-003Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
Bristol Myers SquibbZERIT XRstavudineCAPSULE, EXTENDED RELEASE;ORAL021453-002Dec 31, 2002DISCNNoNo► Subscribe► SubscribeY
TheratechnologiesEGRIFTAtesamorelin acetatePOWDER;SUBCUTANEOUS022505-001Nov 10, 2010RXYesYes► Subscribe► SubscribeREDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
TheratechnologiesEGRIFTAtesamorelin acetatePOWDER;SUBCUTANEOUS022505-002Nov 29, 2011DISCNNoNo► Subscribe► SubscribeREDUCTION OF EXCESS ABDOMINAL FAT IN HIV-INFECTED PATIENTS WITH LIPODYSTROPHY
Boehringer IngelheimGLYXAMBIempagliflozin; linagliptinTABLET;ORAL206073-002Jan 30, 2015RXYesYes► Subscribe► SubscribeMETHOD OF TREATING TYPE 2 DIABETES MELLITUS BY ADMINISTERING LINAGLIPTIN IN COMBINATION WITH EMPAGLIFLOZIN
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Healthtrust
Chinese Patent Office
Cantor Fitzgerald
Citi
Baxter
Medtronic
Teva
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot